Cubuk Secil, Uckan Sina, Ozdemir Handan, Taslica Zeynep Firdevs, Bacanli Didem
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Başkent University, İstanbul, Turkey.
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Medipol University, İstanbul, Turkey.
J Oral Maxillofac Pathol. 2020 May-Aug;24(2):400. doi: 10.4103/jomfp.JOMFP_88_18. Epub 2020 Sep 9.
The aim of this study to investigate the efficiency of propranolol on occurrence and development of 4-nitroquinoline 1-oxide (4NQO)-induced squamous cell carcinogenesis of the tongue in rats.
The sample was composed of 27 male Sprague Dawley rats that received 50 ppm 4NQO for 20 weeks in drinking water. Group 1 ( = 9) was treated with 50 mg/kg/day propranolol for 20 weeks, Group 2 ( = 9), after carcinogenesis inducement for 20 weeks, received propranolol (50 mg/kg/day) for 2 weeks and Group 3 ( = 9) received no treatment. At the end of the experimental stage, the tongue specimens were evaluated under a light microscope and categorized as low- or high-risk lesions according to a binary system.
The statistical comparison was performed with a likelihood ratio test.
Histopathological analysis revealed the risk of malignant transformation rates as 33.3% in Group 1, 55.5% in Group 2 and 77.8% in Group 3; however, the difference between the groups was not statistically significant ( > 0.05).
The results of the study suggest that propranolol has a tendency to preventive effect against carcinogenesis.
本研究旨在探讨普萘洛尔对4-硝基喹啉-1-氧化物(4NQO)诱导的大鼠舌鳞状细胞癌发生发展的影响。
样本由27只雄性斯普拉格-道利大鼠组成,它们在饮用水中接受50 ppm的4NQO处理20周。第1组(n = 9)用50 mg/kg/天的普萘洛尔治疗20周,第2组(n = 9)在致癌诱导20周后,接受普萘洛尔(50 mg/kg/天)治疗2周,第3组(n = 9)不接受治疗。在实验阶段结束时,在光学显微镜下评估舌标本,并根据二元系统分为低风险或高风险病变。
采用似然比检验进行统计比较。
组织病理学分析显示,第1组的恶性转化率风险为33.3%,第2组为55.5%,第3组为77.8%;然而,各组之间的差异无统计学意义(P>0.05)。
研究结果表明,普萘洛尔对致癌作用有预防作用倾向。